Eltrombopag: a springboard to early responses in SAA-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Eltrombopag: a springboard to early responses in SAA

Published:2022-01-06 Issue:1 Volume:139 Page:1-2
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Babushok Daria V.¹²^ORCID

Affiliation:

1. University of Pennsylvania and

2. Children’s Hospital of Philadelphia

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

https://ashpublications.org/blood/article-pdf/139/1/1/1857753/bloodbld2021014046c.pdf

Reference9 articles.

1. Long-term outcomes in patients with severe aplastic anemia treated with immunosuppression and eltrombopag: a phase 2 study;Patel;Blood.,2022

2. Eltrombopag for refractory severe aplastic anemia: dosing, duration, long term outcomes and clonal evolution;Winkler;Blood.,2019

3. Eltrombopag and improved hematopoiesis in refractory aplastic anemia;Olnes;N Engl J Med.,2012

4. Eltrombopag added to standard immunosuppression for aplastic anemia;Townsley;N Engl J Med.,2017

5. Cyclosporin A response and dependence in children with acquired aplastic anaemia: a multicentre retrospective study with long-term observation follow-up;Saracco;Br J Haematol.,2008

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First-line treatment of severe aplastic anemia: immunosuppressive therapy plus eltrombopag versus haploidentical hematopoietic stem cell transplantation, a multicenter prospective study;Bone Marrow Transplantation;2024-08-01

2. Modified Delphi panel consensus recommendations for management of severe aplastic anemia;Blood Advances;2024-07-26

3. Efficacy and safety of immunosuppressive therapy combined with eltrombopag for severe aplastic anemia: a systematic review and meta-analysis;Systematic Reviews;2024-04-04

4. Acquired aplastic anemia;The Rose and Mackay Textbook of Autoimmune Diseases;2024

5. Unbiased Single‐Cell Sequencing of Hematopoietic and Immune Cells from Aplastic Anemia Reveals the Contributors of Hematopoiesis Failure and Dysfunctional Immune Regulation;Advanced Science;2023-12-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3